News & Updates

Using a lower glycaemic threshold led to more diagnoses of gestational diabetes, though its impact on maternal and birth outcomes remains uncertain, results of the GEMS* trial showed.

Oral gonadotropin-releasing hormone (GnRH) antagonists help relieve pain in women with endometriosis or dysmenorrhea, according to the results of a meta-analysis.

Researchers have recently developed and validated an 8-item score to calculate the risk of cardiovascular (CV) death and myocardial infarction (MI) in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention.

Obese adults with weight-related complications who do not respond adequately to lifestyle interventions should be offered one of four anti-obesity medications, according to the new clinical practice guideline on pharmacological interventions released by the American Gastroenterological Association (AGA).

Treatment with nelonemdaz, a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, does not appear to significantly improve stroke outcomes as compared with placebo, although nelonemdaz-treated patients show a greater tendency toward achieving modified Rankin Scale scores of 0–2 at 12 weeks, according to the results of a phase II study.

For women with polycystic ovary syndrome (PCOS), if a 5-day letrozole regimen for ovulation induction does not work, extending the duration of treatment may do the job, as shown in a study.